Safety of neonatal hepatitis B vaccine administration
- PMID: 11734710
- DOI: 10.1097/00006454-200111000-00009
Safety of neonatal hepatitis B vaccine administration
Abstract
Objective: To determine whether hepatitis B vaccination of newborns increases the incidence of fever and/or suspected sepsis.
Methods: A prospective clinical study was undertaken at the Kaiser Permanente San Francisco Medical Center involving normal full term newborns born between November 1, 1991, and April 30, 1994. During this time 3302 infants were vaccinated within 21 days of birth with hepatitis B vaccine, and 2353 were not. Clinical and demographic data were collected from Kaiser Permanente's existing clinical information systems, and laboratory data for blood and cerebrospinal fluid (CSF) cultures were obtained from the comprehensive automated regional laboratory reporting system.
Results: There were no significant differences between vaccinated and unvaccinated newborns in the proportion of infants who received care for fever (0.8% vaccinated and 1.1% unvaccinated, P = 0.28), allergic reactions, seizures or other neurologic events in the first 21 days of life. Vaccinated newborns were significantly less likely to undergo microbiologic evaluation for possible sepsis. Among vaccinated newborns 4.0% had blood cultures and 1.6% had CSF cultures. Among infants who were not vaccinated 8.3% had blood cultures and 1.6% had CSF cultures (P <0.001 for both tests).
Conclusion: This study found no evidence that newborn hepatitis B vaccination is associated with an increase in the number of febrile episodes, sepsis evaluations or allergic or neurologic events. In addition our data did not support any increase in medical procedures attributed to receipt of hepatitis B vaccine.
Similar articles
-
A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.Pediatrics. 2008 Dec;122(6):e1179-85. doi: 10.1542/peds.2008-1977. Pediatrics. 2008. PMID: 19047220
-
Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.Vaccine. 2008 Jan 30;26(5):647-52. doi: 10.1016/j.vaccine.2007.11.048. Epub 2007 Dec 7. Vaccine. 2008. PMID: 18155811 Clinical Trial.
-
Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.Pediatrics. 1999 Feb;103(2):E14. doi: 10.1542/peds.103.2.e14. Pediatrics. 1999. PMID: 9925860
-
Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review.Vaccine. 2013 May 17;31(21):2506-16. doi: 10.1016/j.vaccine.2012.12.012. Epub 2012 Dec 17. Vaccine. 2013. PMID: 23257713 Review.
-
The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience.Expert Rev Vaccines. 2017 Aug;16(8):789-809. doi: 10.1080/14760584.2017.1338569. Epub 2017 Jul 3. Expert Rev Vaccines. 2017. PMID: 28586278 Review.
Cited by
-
Exploring the optimal vaccination strategy against hepatitis B virus in childhood (Review).Biomed Rep. 2023 Jun 9;19(1):48. doi: 10.3892/br.2023.1631. eCollection 2023 Jul. Biomed Rep. 2023. PMID: 37383679 Free PMC article. Review.
-
Risks of Infectious Diseases in Newborns Exposed to Alternative Perinatal Practices.Pediatrics. 2022 Feb 1;149(2):e2021055554. doi: 10.1542/peds.2021-055554. Pediatrics. 2022. PMID: 35104357 Free PMC article. Review.
-
Hepatitis B vaccine development and implementation.Hum Vaccin Immunother. 2020 Jul 2;16(7):1533-1544. doi: 10.1080/21645515.2020.1732166. Epub 2020 Mar 18. Hum Vaccin Immunother. 2020. PMID: 32186974 Free PMC article.
-
Neonatal seizures: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.Vaccine. 2019 Dec 10;37(52):7596-7609. doi: 10.1016/j.vaccine.2019.05.031. Vaccine. 2019. PMID: 31783981 Free PMC article. Review. No abstract available.
-
Pharmacovigilance in children: detecting adverse drug reactions in routine electronic healthcare records. A systematic review.Br J Clin Pharmacol. 2015 Oct;80(4):844-54. doi: 10.1111/bcp.12645. Epub 2015 May 28. Br J Clin Pharmacol. 2015. PMID: 25819310 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous